TriaGen Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,200
Closed -$11K 168
2020
Q4
$11K Buy
+4,200
New +$347K 0.01% 170

Other funds holding CL

TriaGen Wealth Management's CL Position: Q1 2022 in Review

TriaGen Wealth Management sold out of Colgate-Palmolive (CL) in Q1 2022, closing a stake of 20,392 shares — an estimated $1.74M sold.

TriaGen Wealth Management first reported a position in CL in Q4 2020 and held it in 5 quarters. The position peaked at $1.81M in Q4 2020. 1,632 funds tracked by Wall St. Rank hold CL as of Q1 2022.

  • TriaGen Wealth Management reported no remaining Colgate-Palmolive position as of Q1 2022 after selling out during the quarter.
  • TriaGen Wealth Management sold 20,392 Colgate-Palmolive shares in Q1 2022, an estimated $1.74M.
  • TriaGen Wealth Management first reported a position in Colgate-Palmolive in Q4 2020 and held it in 5 quarters.
  • TriaGen Wealth Management's Colgate-Palmolive position peaked at $1.81M in Q4 2020.
  • 1,632 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2022.

Based on TriaGen Wealth Management's 13F filing for Q1 2022, filed 29 Apr 2022.